National Survey on Asthma
Completed
- Conditions
- Asthma
- Registration Number
- NCT00770250
- Lead Sponsor
- AstraZeneca
- Brief Summary
To evaluate the concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 1704
Inclusion Criteria
- A diagnosis of persistent asthma treated with an inhaled corticosteroid based maintenance treatment for more than 3 months
- Given his/her consent to participate to the study and who is able to answer the questionnaire in french by him/her-self.
Exclusion Criteria
- Patient with a cardiac disease (congestive heart failure, coronary artery disease)
- Patient with a respiratory disease other than asthma (COPD, sleep apnea syndrome).
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The concordance of the most frequently used words by the patients and the physicians to express asthma symptoms, according to the patient's level of asthma control. Once
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie asthma symptom expression in NCT00770250?
How does NCT00770250 compare to standard-of-care asthma treatments in general medicine?
What biomarkers correlate with asthma control levels in patient-physician communication studies?
What adverse events are associated with asthma management strategies in observational trials?
How do AstraZeneca's asthma research initiatives relate to other bronchodilator therapies?
Trial Locations
- Locations (1)
Research Site
🇫🇷Zuydcoote, France
Research Site🇫🇷Zuydcoote, France